Widening gap between cervical cancer screenings safe for some

2016 ◽  
Vol 31 (8) ◽  
pp. 16-16
Keyword(s):  
Cervical Cancer ◽  
Cancer Screenings

Financial hardship is associated with lower uptake of colorectal, breast, and cervical cancer screenings

2021 ◽  
Author(s):  
Monica L. Kasting ◽  
David A. Haggstrom ◽  
Joy L. Lee ◽  
Stephanie L. Dickinson ◽  
Cleveland G. Shields ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Financial Hardship ◽  
Breast And Cervical Cancer ◽  
Cancer Screenings

scholarly journals Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings

2018 ◽  
Vol 34 (3) ◽  
pp. 341-343 ◽  
Author(s):  
Sudha R. Raman ◽  
Jeffrey S. Brown ◽  
Lesley H. Curtis ◽  
Kevin Haynes ◽  
James Marshall ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Health Data ◽  
Cancer Screenings ◽  
Electronic Health

scholarly journals Shared Decision-Making and Women’s Adherence to Breast and Cervical Cancer Screenings

2018 ◽  
Vol 15 (7) ◽  
pp. 1509 ◽  
Author(s):  
Jayoung Han ◽  
Paiboon Jungsuwadee ◽  
Olufunmilola Abraham ◽  
Dongwoo Ko
Keyword(s):  
Cervical Cancer ◽  
Decision Making ◽  
Shared Decision Making ◽  
Adherence Rate ◽  
Shared Decision ◽  
Composite Measure ◽  
Cancer Society ◽  
Breast And Cervical Cancer ◽  
Cancer Screenings ◽  
Screening Adherence

We examined the effect of shared decision-making (SDM) on women’s adherence to breast and cervical cancer screenings and estimated the prevalence and adherence rate of screenings. The study used a descriptive cross-sectional design using the 2017 Health Information National Trends Survey (HINTS) data collected by the National Cancer Institute. Adherence was defined based on the guidelines from the American Cancer Society and the composite measure of shared decision-making was constructed using three items in the data. Multivariable logistic regression was performed to examine the association between the SDM and adherence, controlling for cancer beliefs and socio-demographic variables. The analysis included 742 responses. Weighted to represent the U.S. population, 68.1% adhered to both breast and cervical cancer screening guidelines. The composite measure of SDM was reliable (α = 0.85), and a higher SDM score was associated with women’s screening adherence (b = 0.17; p = 0.009). There were still women who did not receive cancer screenings as recommended. The results suggest that the use of the SDM approach for healthcare professionals’ communication with patients can improve screening adherence.

Intrinsic Factors of Non-adherence to Breast and Cervical Cancer Screenings Among Latinas

2015 ◽  
Vol 3 (4) ◽  
pp. 658-666 ◽  
Author(s):  
Karent Zorogastua ◽  
Deborah Erwin ◽  
Linda Thelemaque ◽  
LeaVonne Pulley ◽  
Lina Jandorf
Keyword(s):  
Cervical Cancer ◽  
Intrinsic Factors ◽  
Breast And Cervical Cancer ◽  
Cancer Screenings

Factors and trends in cancer screening in the United States from 2004 to 2010.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1565-1565
Author(s):  
Thanyanan Reungwetwattana ◽  
Julian R. Molina ◽  
Jeanette Y. Ziegenfuss
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Cervical Cancer Screening ◽  
Prostate Cancer Screening ◽  
Cancer Screenings ◽  
The Us ◽  
Race Ethnicity

1565 Background: Understanding the prevalence of cancer screening in the US and the factors associated with its accessibility is important for public health promotion. Methods: The 2004 and 2010 Behavioral Risk Factor Surveillance Systems were used to ascertain cancer screening rates among populations indicated for each test by age, gender, and the American Cancer Society recommendation for cancer screenings [fecal occult blood test (FOBT) or endoscopy for colorectal cancer (CRC) screening, digital rectal examination (DRE) or prostate specific antigen (PSA) for prostate cancer screening, clinical breast examination (CBE) or mammogram for breast cancer screening, and Papanicolaou (Pap) test for cervical cancer screening]. Results: Over this period, CRC and breast cancer screening rates significantly increased (15.9%, 13.9%) while prostate and cervical cancer screening rates significantly decreased (1.2%, 5.2%). Race/ethnicity might be an influence in CRC and cervical cancer screening accessibility. Prostate cancer screening accessibility might be influenced by education and income. The older-aged populations (70-79, >79) had high prevalence of CRC, prostate and breast cancer screenings even though there is insufficient evidence for the benefits and harms of screenings in the older-aged group. Conclusions: The disparities in age, race/ethnicity, health insurance, education, employment, and income for the accession to cancer screening of the US population have decreased since 2004. The trajectory of increasing rates of CRC and breast cancer screenings should be maintained. To reverse the trend, the causes of the decreased rate of cervical cancer screening and the high rates of screenings in older-aged populations should, however, be further explored. [Table: see text]

scholarly journals Can mystery patients evaluate the quality of cervical cancer screenings? A pilot study in Bolivia

2021 ◽  
Vol 23 (4) ◽  
pp. 1-8
Author(s):  
Sarah Sullivan ◽  
Maria Teresa Solis ◽  
Sahai Burrowes ◽  
Armando Basagoitia
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Pilot Study ◽  
Health Education ◽  
Missing Observations ◽  
Test Results ◽  
Papanicolaou Test ◽  
Cancer Screenings ◽  
Local Officials

Objective This pilot study assesses the feasibility of using mystery patients to evaluate cervical cancer screenings provided to women in rural Bolivia. Methods We developed a protocol with local officials and adapted and pre-tested a debriefing tool. Eight mystery patients with existing appointments at four purposively selected rural facilities were recruited and trained. An interviewer debriefed patients after their screenings, and entered responses into a spreadsheet for analysis. Ques- tionnaire response frequencies and missing observations were presented. Results All patients completed screening and debriefing. On average, 93% of the questions were completed, with non-responses largely due to questions that were irrelevant to the screening venue. Responses revealed problems with confidentiality and dignity, minimal exam explanations or health education, inconsistencies across health facilities in Papanicolaou test availability, and problems in delivering and receiving test results. Conclusion Our findings suggest that the mystery patient method can be useful in evaluating the quality of cervical cancer screening and the delivery of test results in rural Bolivia.

scholarly journals HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness

2021 ◽  
Author(s):  
Julia Seay ◽  
Rayna Matsuno ◽  
Jennifer Buechel ◽  
Karen Tannenbaum ◽  
Natalie Wells
Keyword(s):  
Cervical Cancer ◽  
Hpv Vaccination ◽  
The United States ◽  
Hpv Infection ◽  
Active Duty ◽  
Future Research ◽  
Policy Recommendations ◽  
Military Health ◽  
Cancer Screenings ◽  
Uptake Rates

ABSTRACT The incidence of human papillomavirus (HPV) related cancers is growing in the United States. Active duty service members (ADSM) have higher rates of HPV infection than civilians and are therefore at greater risk of developing HPV-related cancers. The purpose of this commentary is to examine the burden of HPV-related cancers in ADSM. The current HPV vaccination and cervical cancer screening uptake rates of U.S. ADSM are presented, including a literature review of military-focused studies on HPV vaccination and cervical cancer screenings. We provide directions for future research, interventions, and policy recommendations to improve HPV-related cancer prevention among ADSM.

The Mitigation of Racial Disparities in Cervical Cancer Screening Among U.S. Active Duty Service Women

2020 ◽  
Author(s):  
Jessica Pope ◽  
Amanda Banaag ◽  
Cathaleen Madsen ◽  
Tranessia Hanson ◽  
Munziba Khan ◽  
...  
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Native American ◽  
Cancer Screening ◽  
Racial Disparities ◽  
Cervical Cancer Screening ◽  
Active Duty ◽  
Cancer Screenings ◽  
Women In The Navy ◽  
The U.S

Abstract Introduction The U.S. Preventive Services Task Force recommends regular cervical cancer screening for women aged 21-65 years. Such screening is key to reducing mortality and morbidity. Despite improvement in the screening rate, cervical cancer still disproportionately affects women of minority groups because of access to quality health care. The Military Health System (MHS) mitigates this barrier through universal healthcare coverage for all active duty service members and their families. However, such racial/ethnic disparities, seen in civilian population, have not been studied in the MHS. Materials and Methods This is a retrospective cross-sectional study utilizing fiscal years 2011-2016 claims data obtained from the MHS Data Repository for 112,572 active duty service women aged 21-64 years. Study analyses included descriptive statistics on patient demographics, calculations of the proportion of patients who received cervical cancer screenings as well as the proportion of patients in compliance with USPSTF guidelines, and unadjusted odds ratios for the likelihood of compliance by race and military service. Results Of the study population, 50.0% of active duty women were screened for cervical cancer. When compared to White women, Black (1.05 OR, 1.03-1.08 CI), Native American/Alaskan Native (1.26 OR, 1.15-1.39 CI), and Other (1.12 OR, 1.06-1.18 CI) women were significantly more likely to receive cervical cancer screenings. The proportions of 3-year compliance were relatively equal within each race category (ranging from 43% to 45%), with no significant findings for the odds of compliance in any race when compared to White active duty women; however, proportions of 3-year compliance by service ranged from 11.7% in the Marines to 84.4% in the Navy, and active duty women in the Navy were six times more likely to be in compliance with guidelines than women in the Army. When looking at 5-year compliance in active duty women aged 30-64 years, women in the Navy were more likely than women in the Army to meet compliance guidelines (1.24 OR, 1.14-1.36 CI), while women in the Air Force were slightly less likely (0.90 OR, 0.82-0.98 CI). Conclusions The women in our population demonstrated similar or lower compliance than other studies conducted in the U.S. general population, and racial disparities for cervical cancer screening were partially mitigated in active duty service women. While our research demonstrates that universal insurance can help provide equal access and care, investigation into the factors that encourage greater usage among members of different military branches may help to understand and develop policies to improve health care systems.

Sign in / Sign up

Export Citation Format

Share Document